- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00342082
Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants
A Pilot Study to Investigate Micronucleated Erythrocyte Frequencies in Infants Exposed to Nucleoside Antiretrovial Drugs in Utero and for 6 Weeks Postnatally
This collaborative investigation between NIEHS, Duke University, and the University of North Carolina (UNC) will study red blood cells of babies born to HIV-infected women receiving anti-retroviral treatment. Studies have shown that newborn mice whose mothers were given anti-HIV medications during pregnancy had abnormal red blood cells circulating in their blood stream, indicating genetic damage to the cells caused by the anti-HIV medications. It is not known if similar red blood cell abnormalities develop in human infants whose mothers received anti-HIV medication during their pregnancy. This study will examine red blood cells from infants exposed to anti-HIV medications and from non-exposed infants to look for differences between them involving this specific genetic damage.
Healthy pregnant women and HIV-infected pregnant women who received antiretroviral treatment during their last trimester of pregnancy and during labor may be eligible for this study. Babies of HIV-infected women are also included in the study. Candidates will be recruited from medical centers at Duke University and the UNC. HIV-infected mothers must plan to have their baby followed by either the UNC or the Duke Pediatric Infectious Disease clinic.
All women in the study will have 1 milliliter (less than 1/2 teaspoon) of blood collected for this study during delivery at the same time that other blood samples are obtained for their medical care. In addition, 5 ml (1 teaspoon) of umbilical cord blood will also be collected for this study at the time of delivery after the cord is no longer attached to the baby. This concludes participation of non-HIV infected women.
Babies born to HIV-infected mothers will have 1 ml of blood drawn between 0 to 3 days of life, between 4 to 6 weeks of life, and between 4 to 6 months of life. These bloodsamples will be collected at the same time as other routine scheduled blood draws.
Study Overview
Status
Conditions
Detailed Description
This is an observational study of pregnant women and their newborns. The population will include 10 HIV infected women on any antiretroviral regimen and their newborn infants and 10 healthy women on no antiretroviral regimen and their newborn infants.
Primary Objective: To determine if micronucleated erythrocytes can be detected more frequently in cord blood of infants exposed to zidovudine in utero and intrapartum compared to cord blood from infants not exposed.
Secondary Objectives:
- To determine if micronucleated erythrocytes can be detected in pregnant women on any antiretrovial agents.
- To determine if micronucleated erythrocytes change in frequency in infants exposed to antiretrovial agents over the first 6 weeks of life, during the time the infant is exposed to Zidovudine.
- To determine the change in micronucleated erythrocytes in the infants after cessation or Zidovudine (6 months).
Study Type
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599-7030
- University of North Carolina Hospitals
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
Research Triangle Park, North Carolina, United States, 27709
- NIEHS, Research Triangle Park
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- INCLUSION CRITERIA: (Treated Group)
- HIV-infected
- Pregnant
- Treatment with antiretroviral regimen
INCLUSION CRITERIA: (Control Group)
-Healthy Pregnant Female
EXCLUSION CRITERIA: (Treated Group)
-None
EXCLUSION CRITERIA: (Control Group)
-Delivery less than 32 weeks gestation
Study Plan
How is the study designed?
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 999904242
- 04-E-N242
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cord Blood
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
Institut Universitari DexeusRecruitingUmbilical Cord BloodSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); RevimmuneWithdrawnRecombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood TransplantationUmbilical Cord Blood Transplant
-
Ankara UniversityMiddle East Technical UniversityCompletedCesarean | Cord Blood CollectionTurkey
-
Icahn School of Medicine at Mount SinaiJames J. Peters Veterans Affairs Medical CenterRecruiting
-
Lawson Health Research InstituteThe Physicians' Services Incorporated FoundationCompletedCentral Cord SyndromeCanada
-
moshe yeshurunGlaxoSmithKlineUnknownPediatric Patients Undergoing Allogeneic Cord Blood Transplantation.Israel
-
Shirley Ryan AbilityLabNational Institute on Disability, Independent Living, and Rehabilitation...Recruiting
-
Gaziler Physical Medicine and Rehabilitation Education...CompletedTraumatic Spinal Cord InjuryTurkey
-
Skolkovo Institute of Science and TechnologySamara State Medical University; Kazan Federal University; Samara Regional Clinical... and other collaboratorsRecruitingStroke | Spinal Cord InjuriesRussian Federation